Today's Clinical Lab - News, Editorial and Products for the Clinical Laboratory
A collaborative team from Penn State and the World Health Organization (WHO) has created a novel method to predict measles vaccination levels using routinely collected clinical data from suspected measles cases.
A collaborative team from Penn State and the World Health Organization (WHO) has created a novel method to predict measles vaccination levels using routinely collected clinical data from suspected measles cases.
istock, _jure

New Model Predicts Measles Vaccination Coverage Using Routine Clinical Data

Researchers develop an innovative, cost-effective method to estimate regional measles vaccination levels in real time, helping guide public health responses 

Logo
Today's Clinical Lab
Logo

Today’s Clinical Lab is a reader-centric publication that keeps clinical professionals up to date with today’s rapidly changing lab industry with in-depth and timely editorial content and resources, including clinical industry news and insights into the latest trends, technologies, and techniques in the clinical lab.

ViewFull Profile
Learn about ourEditorial Policies.
Published:Aug 08, 2025
|1 min read
Register for free to listen to this article
Listen with Speechify
0:00
1:00

Accurate, timely data on vaccination coverage is critical for managing measles outbreaks, yet many regions lack up-to-date information. A collaborative team from Penn State and the World Health Organization (WHO) has created a novel method to predict measles vaccination levels using routinely collected clinical data from suspected measles cases. Published in Vaccine, the model offers a more accessible and rapid alternative to traditional surveys, which are expensive, infrequent, or prone to bias.

Conventional vaccination data comes primarily from Demographic and Health Surveys (DHS)—considered the gold standard but conducted only every 3 to 5 years—and from administrative coverage estimates based on vaccine doses administered. The DHS surveys are costly and often outdated by the time results are available, especially in low- and middle-income countries where measles impacts are greatest.

The new method leverages three clinical indicators: the mean age of patients presenting with suspected measles, their reported vaccination status, and confirmation of actual measles infection versus other illnesses. Using these predictors, the researchers trained a regression model to estimate vaccination coverage, showing strong correlation with DHS data while outperforming administrative estimates.

“Since our method uses routinely collected information that is readily available to researchers and public health officials, it provides a cheap and more easily accessible methodology to estimate vaccination coverage for a region that can be done quickly and can help inform policy in a timelier way,” said Deepit Bhatia, first author and Penn State graduate student.

With DHS funding currently paused, this tool offers a timely stopgap for tracking vaccination coverage and guiding interventions to prevent outbreaks. The work was supported by the Bill & Melinda Gates Foundation and multiple US federal agencies.

Reference:

Bhatia D, Crowcroft N, Antoni S, et al. Prediction of subnational-level vaccination coverage estimates using routine surveillance data and survey data. Vaccine. 2025;60:127277. doi:10.1016/j.vaccine.2025.127277